Nektar Therapeutics
NKTR
#4575
Rank
NZ$3.76 B
Marketcap
NZ$131.16
Share price
2.03%
Change (1 day)
884.79%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$0.32 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are NZ$0.32 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.32 B-23.67%
2024-12-31NZ$0.43 B2.08%
2023-12-31NZ$0.42 B-22.05%
2022-12-31NZ$0.54 B-15.45%
2021-12-31NZ$0.64 B0.19%
2020-12-31NZ$0.63 B-24.69%
2019-12-31NZ$0.84 B31.69%
2018-12-31NZ$0.64 B8.79%
2017-12-31NZ$0.59 B-14.58%
2016-12-31NZ$0.69 B-3.5%
2015-12-31NZ$0.71 B39.03%
2014-12-31NZ$0.51 B-18.95%
2013-12-31NZ$0.63 B16.46%
2012-12-31NZ$0.54 B4.63%
2011-12-31NZ$0.52 B-6.16%
2010-12-31NZ$0.55 B-14.33%
2009-12-31NZ$0.65 B2.07%
2008-12-31NZ$0.63 B-4.26%
2007-12-31NZ$0.66 B-13.2%
2006-12-31NZ$0.76 B-1.27%
2005-12-31NZ$0.77 B99.99%
2004-12-31NZ$0.38 B-44.13%
2003-12-31NZ$0.69 B-8.87%
2002-12-31NZ$0.76 B-20.07%
2001-12-31NZ$0.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$202.43 B 61,642.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$208.83 B 63,594.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$140.94 B 42,890.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$24.00 B 7,221.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$144.86 B 44,084.41%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$112.43 B 34,193.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$74.47 M-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.14 B 250.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland